Disorder-function relationships for the cell cycle regulatory proteins p21 and p27

Biological Chemistry

Volumn 393, Issue 4, 2012, Pages 259-274

  Mitrea, Diana M ^a   Yoon, Mi Kyung ^a   Ou, Li ^a   Kriwacki, Richard W ^a  

^a ST JUDE CHILDREN S RESEARCH HOSPITAL   (United States)

Author keywords

Cell cycle regulator; Disorder function; Intrinsically disordered proteins; P21; P27; Signaling conduit

Indexed keywords

CYCLIN A; CYCLIN DEPENDENT KINASE; CYCLIN DEPENDENT KINASE 2; CYCLIN DEPENDENT KINASE 4; CYCLINE; PROTEIN P21; PROTEIN P27;

ACETYLATION; APOPTOSIS; BIOSYNTHESIS; CELL CYCLE REGULATION; CELL DIVISION; CELL FATE; CELL MIGRATION; CELL ORGANELLE; CELL PROLIFERATION; CIRCULAR DICHROISM; CONFERENCE PAPER; CYTOSKELETON; G1 PHASE CELL CYCLE CHECKPOINT; G2 PHASE CELL CYCLE CHECKPOINT; GENE FUNCTION; GENETIC REGULATION; GENETIC TRANSCRIPTION; HUMAN; M PHASE CELL CYCLE CHECKPOINT; METABOLISM; METHYLATION; MISSENSE MUTATION; MOLECULAR DYNAMICS; NEOPLASM; NUCLEAR MAGNETIC RESONANCE SPECTROSCOPY; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEIN BINDING; PROTEIN FUNCTION; PROTEIN STRUCTURE; S PHASE CELL CYCLE CHECKPOINT; SUMOYLATION; UBIQUITINATION;

ANIMALS; CYCLIN-DEPENDENT KINASE INHIBITOR P21; CYCLIN-DEPENDENT KINASE INHIBITOR P27; HUMANS; PHOSPHORYLATION; SIGNAL TRANSDUCTION;

EID: 84859824182     PISSN: 14316730     EISSN: 14374315     Source Type: Journal    
DOI: 10.1515/hsz-2011-0254     Document Type: Conference Paper

References (119)

1. Abbas, T., Sivaprasad, U., Terai, K., Amador, V., Pagano, M., and Dutta, A. (2008). PCNA-dependent regulation of p21 ubiquitylation and degradation via the CRL4Cdt2 ubiquitin ligase complex. Genes Dev. 22, 2496-2506.
2. Adams, P.D., Sellers, W.R., Sharma, S.K., Wu, A.D., Nalin, C.M., and Kaelin, W.G. Jr. (1996). Identification of a cyclin-cdk2 recognition motif present in substrates and p21-like cyclin-dependent kinase inhibitors. Mol. Cell. Biol. 16, 6623-6633. (Pubitemid 26389720)
3. Adkins, J.N. and Lumb, K.J. (2000). Stoichiometry of cylin A-cyclin dependent kinase 2 inhibition by p21 Cip1/Waf1. Biochemistry 39, 13925-13930.
4. Amador, V., Ge, S., Santamaria, P.G., Guardavaccaro, D., and Pagano, M. (2007). APC/C(Cdc20) controls the ubiquitin-mediated degradation of p21 in prometaphase. Mol. Cell 27, 462-473. (Pubitemid 47126938)
5. Babu, M., van der Lee, R., de Groot, N., and Gspooner, J. (2011). Intrinsically disordered proteins: regulation and disease. Curr. Opin. Struct. Biol. 21, 432-440.
6. Besson, A., Gurian-West, M., Schmidt, A., Hall, A., and Roberts, J.M. (2004). p27 Kip1 modulates cell migration through the regulation of RhoA activation. Genes Dev. 18, 862-876. (Pubitemid 38529656)
7. Bienkiewicz, E.A., Adkins, J.N., and Lumb, K.J. (2002). Functional consequences of preorganized helical structure in the intrinsically disordered cell-cycle inhibitor p27 Kip1. Biochemistry 41, 752-759. (Pubitemid 34061975)
8. Blain, S.W. (2008). Switching cyclin D-Cdk4 kinase activity on and off. Cell Cycle 7, 892-898. (Pubitemid 351573783)
9. Blain, S.W. and Massague, J. (2002). Breast cancer banishes p27 from nucleus. Nat. Med. 8, 1076-1078. (Pubitemid 35175956)
10. Boehr, D.D., Nussinov, R., and Wright, P.E. (2009). The role of dynamic conformational ensembles in biomolecular recognition. Nat. Chem. Biol. 5, 789-796.
11. Bornstein, G., Bloom, J., Sitry-Shevah, D., Nakayama, K., Pagano, M., and Hershko, A. (2003). Role of the SCF Skp2 ubiquitin ligase in the degradation of p21 Cip1 in S phase. J. Biol. Chem. 278, 25752-25757. (Pubitemid 36835332)
12. Borriello, A., Bencivenga, D., Criscuolo, M., Caldarelli, I., Cucciolla, V., Tramontano, A., Borgia, A., Spina, A., Oliva, A., Naviglio, S., et al. (2011a). Targeting p27 Kip1 protein: its relevance in the therapy of human cancer. Exp. Opin. Ther. Targets. 15, 677-693.
13. Borriello, A., Caldarelli, I., Bencivenga, D., Criscuolo, M., Cucciolla, V., Tramontano, A., Oliva, A., Perrotta, S., and Della Rangione, F. (2011b). p57 Kip2 and cancer: time for a critical appraisal. Mol. Cancer Res. 9, 1269-1284.
14. Brown, C.J., Johnson, A.K., and Daughdrill, G.W. (2010). Comparing models of evolution for ordered and disordered proteins. Mol. Biol. Evol. 27, 609-621.
15. Carrano, A.C., Eytan, E., Hershko, A., and Pagano, M. (1999). SKP2 is required for ubiquitin-mediated degradation of the CDK inhibitor p27. Nat. Cell Biol. 1, 193-199. (Pubitemid 129500937)
16. Chen, J., Jackson, P.K., Kirschner, M.W., and Dutta, A. (1995). Separate domains of p21 involved in the inhibition of Cdk kinase and PCNA. Nature 374, 386-388.
17. Chen, J., Saha, P., Kornbluth, S., Dynlacht, B.D., and Dutta, A. (1996). Cyclin-binding motifs are essential for the function of p21 CIP1. Mol. Cell. Biol. 16, 4673-4682. (Pubitemid 26272120)
18. Chen, X., Chi, Y., Bloecher, A., Aebersold, R., Clurman, B.E., and Roberts, J.M. (2004). N-acetylation and ubiquitin-independent proteasomal degradation of p21 Cip1. Mol. Cell 16, 839-847. (Pubitemid 39586541)
19. Cheng, M., Olivier, P., Diehl, J.A., Fero, M., Roussel, M.F., Roberts, J.M., and Sherr, C.J. (1999). The p21 Cip1 and p27 Kip1 CDK'inhibitors are essential activators of cyclin D-dependent kinases in murine fibroblasts. EMBO J. 18, 1571-1583. (Pubitemid 29127070)
20. Chu, I., Sun, J., Arnaout, A., Kahn, H., Hanna, W., Narod, S., Sun, P., Tan, C.K., Hengst, L., and Slingerland, J. (2007). p27 Phosphorylation by Src regulates inhibition of cyclin E-Cdk2. Cell 128, 281-294. (Pubitemid 46123510)
21. Coleman, M.L., Marshall, C.J., and Olson, M.F. (2003). Ras promotes p21 Waf1/Cip1 protein stability via a cyclin D1-imposed block in proteasome-mediated degradation. EMBO J. 22, 2036-2046. (Pubitemid 36565529)
22. Connor, M.K., Kotchetkov, R., Cariou, S., Resch, A., Lupetti, R., Beniston, R.G., Melchior, F., Hengst, L., and Slingerland, J.M. (2003). CRM1/Ran-mediated nuclear export of p27 Kip1 involves a nuclear export signal and links p27 export and proteolysis. Mol. Biol. Cell 14, 201-213. (Pubitemid 36106030)
23. Davey, N.E., Trave, G., and Gibson, T.J. (2011). How viruses hijack cell regulation. Trends Biochem. Sci. 36, 159-169.
24. Day, P.J., Cleasby, A., Tickle, I.J., O'Reilly, M., Coyle, J.E., Holding, F.P., McMenamin, R.L., Yon, J., Chopra, R., Lengauer, C., et al. (2009). Crystal structure of human CDK4 in complex with a D-type cyclin. Proc. Natl. Acad. Sci. USA 106, 4166-4170.
25. Dunker, A.K., Obradovic, Z., Romero, P., Garner, E.C., and Brown, C.J. (2000). Intrinsic. protein disorder in complete genomes. Genome Inform. Ser. Workshop Genome Inform. 11, 161-171.
26. Dyson, H.J. (2011). Expanding the proteome: disordered and alternatively folded proteins. Q. Rev. Biophys. 44, 467-518.
27. Dyson, H.J. and Wright, P.E. (2005). Intrinsically unstructured proteins and their functions. Nat. Rev. Mol. Cell. Biol. 6, 197-208. (Pubitemid 40314921)
28. El-Deiry, W.S., Harper, J.W., Connor, P.M., Velculescu, V.E., Canman, C.E., Jackman, J., Pietenpol, J.A., Burrell, M., Hill, D.E., Wang, Y., et al. (1994). WAF1/CIP1 in induced in p53-mediated G1 arrest and apoptosis. Cancer Res. 54, 1169-1174. (Pubitemid 24108052)
29. Esteve, V., Canela, N., Rodrigues-Vilarrupla, A., Aligue, R., Agell, N., Mingarro, I., Bachs, O., and Perez-Paya, E. (2003). The structural plasticity of the C terminus of p21 Cip is a determinant for target protein recognition. ChemBioChem 4, 863-869. (Pubitemid 37185698)
30. Frescas, D. and Pagano, M. (2008). Deregulated proteolysis by the F-box proteins SKP2 and β-TrCP: tipping the scales of cancer. Nat. Rev. Cancer 8, 438-449. (Pubitemid 351744963)
31. Funk, J.O. and Galloway, D.A. (1998). Inhibiting CDK inhibitors: new lessons from DNA tumor viruses. Trends Biochem. Sci. 23, 337-341. (Pubitemid 28461865)
32. Galea, C.A., Pagala, V.R., Obenauer, J.C., Park, C.G., Slaughter, C.A., and Kriwacki, R.W. (2006). Proteomic studies of the intrinsically unstructured mammalian proteome. J. Proteome Res. 5, 2839-2848. (Pubitemid 44595184)
33. Galea, C.A., Nourse, A., Wang, Y., Sivakolundu, S.G., Heller, W.T., and Kriwacki, R.W. (2008a). Role of intrinsic flexibility in signal transduction mediated by the cell cycle regulator, p27 Kip1. J. Mol. Biol. 376, 827-838.
34. Galea, C.A., Wang, Y., Sivakolundu, S.G., and Kriwacki, R.W. (2008b). Regulation of cell division by intrinsically unstructured proteins: intrinsic flexibility, modularity, and signaling conduits. Biochemistry 47, 7598-7609. (Pubitemid 352019491)
35. Galea, C.A., High, A.A., Obenauer, J.C., Mishra, A., Park, C.G., Punta, M., Schlessinger, A., Ma, J., Rost, B., Slaughter, C.A., et al. (2009). Large-scale analysis of thermostable, mammalian proteins provides insights into the intrinsically disordered proteome. J. Proteome Res. 8, 211-226.
36. Gnad, F., Gunawardena, J., and Mann, M. (2011). PHOSIDA 2011: the posttranslational modification database. Nucleic Acids Res. 39, D253-D260.
37. Grimmler, M., Wang, Y., Mund, T., Cilensek, Z., Keidel, E.M., Waddell, M.B., Jakel, H., Kullmann, M., Kriwacki, R.W., and Hengst, L. (2007). Cdk-inhibitory activity and stability of p27 Kip1 are directly regulated by oncogenic tyrosine kinases. Cell 128, 269-280. (Pubitemid 46123508)
38. Gsponer, J., Futschik, M.E., Teichmann, S.A., and Babu, M.M. (2008). Tight regulation of unstructured proteins: from transcript synthesis to protein degradation. Science 322, 1365-1368. (Pubitemid 352775246)
39. Guan, K.L., Jenkins, C.W., Li, Y., Nichols, M.A., Wu, X., O'Keefe, C.L., Matera, A.G., and Xiong, Y. (1994). Growth suppression by p18, a p16INK4/MTS1 and p14INK4B/MTS2-related CDK6 inhibitor, correlates with wild-type pRb function. Genes Dev. 8, 2939-2952.
40. Gulbis, J.M., Kelman, Z., Hurwitz, J., O'Donnell, M., and Kuriyan, J. (1996). Structure of the C-terminal region of p21 WAF1/CIP1 complexed with human PCNA. Cell 87, 297-306. (Pubitemid 26359007)
41. Hannon, G.J. and Beach, D. (1994). p15ink4b is a potential effector of TGF-β-induced cell cycle arrest. Nature 371, 257-261.
42. Hao, B., Zheng, N., Schulman, B.A., Wu, G., Miller, J.J., Pagano, M., and Pavletich, N.P. (2005). Structural basis of the Cks1-dependent recognition of p27 Kip1 by the SCF Skp2 ubiquitin ligase. Mol. Cell 20, 9-19. (Pubitemid 41396558)
43. Harbour, J.W., Luo, R.X., Dei Santi, A., Postigo, A.A., and Dean, D.C. (1999). Cdk phosphorylation triggers sequential intramolecular interactions that progressively block Rb functions as cells move through G1. Cell 98, 859-869. (Pubitemid 29446902)
44. Harper, J.W., Elledge, S.J., Keyomarsi, K., Dynlacht, B., Tsai, L.H., Zhang, P., Dobrowolski, S., Bai, C., Connell-Crowley, L., Swindell, E., et al. (1995). Inhibition of cyclin-dependent kinases by p21. Mol. Biol. Cell 6, 387-400.
45. Hengst, L. and Reed, S.I. (1996). Translational control of p27 Kip1 accumulation during the cell cycle. Science 271, 1861-1864.
46. Hengst, L., Gopfert, U., Lashuel, H.A., and Reed, S.I. (1998). Complete inhibition of Cdk/cyclin by one molecule of p21 Cip1. Genes Dev. 12, 3882-3888. (Pubitemid 29024850)
47. Hirai, H., Roussel, M.F., Kato, J.Y., Ashmun, R.A., and Sherr, C.J. (1995). Novel INK4 proteins, p19 and p18, are specific inhibitors of the cyclin D-dependent kinases CDK4 and CDK6. Mol. Cell. Biol. 15, 2672-2681.
48. Hyeon, C. and Onuchic, J.N. (2007). Mechanical control of the directional stepping dynamics of the kinesin motor. Proc. Natl. Acad. Sci. USA 104, 17382-17387. (Pubitemid 350219836)
49. Iakoucheva, L.M., Brown, C.J., Lawson, J.D., Obradovic, Z., and Dunker, A.K. (2002). Intrinsic disorder in cell-signaling and cancer- associated proteins. J. Mol. Biol. 323, 573-584. (Pubitemid 35283681)
50. Iakoucheva, L.M., Radivojac, P., Brown, C.J., O'Connor, T.R., Sikes, J.G., Obradovic, Z., and Dunker, A.K. (2004). The importance of intrinsic disorder for protein phosphorylation. Nucleic Acids Res. 32, 1037-1049. (Pubitemid 38854704)
51. Ishida, N., Kitagawa, M., Hatakeyama, S., and Nakayama, K. (2000). Phosphorylation at serine 10, a major phosphorylation site of p27 Kip1, increases its protein stability. J. Biol. Chem. 275, 25146-25154.
52. Ishida, N., Hara, T., Kamura, T., Yoshida, M., Nakayama, K., and Nakayama, K.I. (2002). Phosphorylation of p27Kip1 on serine 10 is required for its binding to CRM1 and nuclear export. J. Biol. Chem. 277, 14355-14358. (Pubitemid 34952496)
53. James, M.K., Ray, A., Leznova, D., and Blain, S.W. (2008). Differential modification of p27(Kip1) controls its cyclin D-cdk4 inhibitory activity. Mol. Cell. Biol. 28, 498-510.
54. Kamura, T., Hara, T., Kotoshiba, S., Yada, M., Ishida, N., Imaki, H., Hatakeyama, S., Nakayama, K., and Nakayama, K.I. (2003). Degradation of p57 Kip2 mediated by SCF Skp2 -dependent ubiquitylation. Proc. Natl. Acad. Sci. USA 100, 10231-10236.
55. Kamura, T., Hara, T., Matsumoto, M., Ishida, N., Okumura, F., Hatakeyama, S., Yoshida, M., Nakayama, K., and Nakayama, K.I. (2004). Cytoplasmic ubiquitin ligase KPC regulates proteolysis of p27 Kip1 at G1 phase. Nat. Cell Biol. 6, 1229-1235. (Pubitemid 39625122)
56. Kim, Y., Starostina, N.G., and Kipreos, E.T. (2008). The CRL4Cdt2 ubiquitin ligase targets the degradation of p21Cip1 to control replication licensing. Genes Dev. 22, 2507-2519.
57. Kotake, Y., Nakayama, K., Ishida, N., and Nakayama, K.I. (2005). Role of serine 10 phosphorylation in p27 stabilization revealed by analysis of p27 knock-in mice harboring a serine 10 mutation. J. Biol. Chem. 280, 1095-1102.
58. Kotoshiba, S., Kamura, T., Hara, T., Ishida, N., and Nakayama, K.I. (2005). Molecular dissection of the interaction between p27 and Kip1 ubiquitylation-promoting complex, the ubiquitin ligase that regulates proteolysis of p27 in G1 phase. J. Biol. Chem. 280, 17694-17700. (Pubitemid 41389006)
59. Kriwacki, R.W. and Yoon, M.K. (2011). Cell biology. Fishing in the nuclear pore. Science 333, 44-45.
60. Kriwacki, R.W., Hengst, L., Tennant, L., Reed, S.I., and Wright, P.E. (1996). Structural studies of p21(waf1/cip1/sdi1) in the free and Cdk2-bound state: conformational disorder mediates binding diversity. Proc. Natl. Acad. Sci. USA 93, 11504-11509.
61. LaBaer, J., Garrett, M.D., Stevenson, L.F., Slingerland, J.M., Sandhu, C., Chou, H.S., Fattaey, A., and Harlow, E. (1997). New functional activities for the p21 family of Cdk inhibitors. Genes Dev. 11, 847-862. (Pubitemid 27175292)
62. Lacy, E.R., Filippov, I., Lewis, W.S., Otieno, S., Xiao, L., Weiss, S., Hengst, L., and Kriwacki, R.W. (2004). p27 binds cyclin-CDK complexes through a sequential mechanism involving bindinginduced protein folding. Nat. Struct. Mol. Biol. 11, 358-364. (Pubitemid 38436801)
63. Lacy, E.R., Wang, Y., Post, J., Nourse, A., Webb, W., Mapelli, M., Musacchio, A., Siuzdak, G., and Kriwacki, R.W. (2005). Molecular basis for the specificity of p27 toward cyclin-dependent kinases that regulate cell division. J. Mol. Biol. 349, 764-773. (Pubitemid 40725953)
64. Larrea, M.D., Hong, F., Wander, S.A., da Silva, T.G., Helfman, D., Lannigan, D., Smith, J.A., and Slingerland, J.M. (2009a). RSK1 drives p27 Kip1 phosphorylation at T198 to promote RhoA inhibition and increase cell motility. Proc. Natl. Acad. Sci. USA 106, 9268-9273.
65. Larrea, M.D., Wander, S.A., and Slingerland, J.M. (2009b). p27 as Jekyll and Hyde: regulation of cell cycle and cell motility. Cell Cycle 8, 3455-3461.
66. Li, R., Waga, S., Hannon, G.J., Beach, D., and Stillman, B. (1994). Differential effects by the p21 CDK inhibitor on PCNA-dependent DNA replication and repair. Nature 371, 534-537. (Pubitemid 24306614)
67. Li, Y., Dowbenko, D., and Lasky, L.A. (2002). AKT/PKB phosphorylation of p21Cip/WAF1 enhances protein stability of p21 Cip /WAF1 and promotes cell survival. J. Biol. Chem. 277, 11352-11361. (Pubitemid 34952901)
68. Liang, J., Zubovitz, J., Petrocelli, T., Kotchetkov, R., Connor, M.K., Han, K., Lee, J.H., Ciarallo, S., Catzavelos, C., Beniston, R., et al. (2002). PKB/Akt phosphorylates p27, impairs nuclear import of p27 and opposes p27-mediated G1 arrest. Nat. Med. 8, 1153-1160. (Pubitemid 35175971)
69. Lu, Z. and Hunter, T. (2010). Ubiquitylation and proteasomal degradation of the p21 Cip1, p27 Kip1 and p57 Kip2 CDK inhibitors. Cell Cycle 9, 12.
70. Luo, Y., Hurwitz, J., and Massague, J. (1995). Cell-cycle inhibition by independent CDK and PCNA binding domains in p21Cip1. Nature 375, 159-161.
71. Mark, W.Y., Liao, J.C., Lu, Y., Ayed, A., Laister, R., Szymczyna, B., Chakrabartty, A., and Arrowsmith, C.H. (2005). Characterization of segments from the central region of BRCA1: an intrinsically disordered scaffold for multiple protein-protein and protein-DNA interactions? J. Mol. Biol. 345, 275-287. (Pubitemid 39574850)
72. McAllister, S.S., Becker-Hapak, M., Pintucci, G., Pagano, M., and Dowdy, S.F. (2003). Novel p27 kip1 C-terminal scatter domain mediates Rac-dependent cell migration independent of cell cycle arrest functions. Mol. Cell. Biol. 23, 216-228. (Pubitemid 36008515)
73. Metallo, S.J. (2010). Intrinsically disordered proteins are potential drug targets. Curr. Opin. Chem. Biol. 14, 481-488.
74. Mittag, T., Kay, L.E., and Forman-Kay, J.D. (2010). Protein dynamics and conformational disorder in molecular recognition. J. Mol. Recognit. 23, 105-116.
75. Montagnoli, A., Fiore, F., Eytan, E., Carrano, A.C., Draetta, G.F., Hershko, A., and Pagano, M. (1999). Ubiquitination of p27 is regulated by Cdk-dependent phosphorylation and trimeric complex formation. Genes Dev. 13, 1181-1189. (Pubitemid 29233148)
76. Morgan, D.O. (1995). Principles of CDK regulation. Nature 374, 131-134.
77. Morgan, J.L., Song, Y., and Barbar, E. (2011). Structural dynamics and multi-region interactions in dynein-dynactin recognition. J. Biol. Chem. 286, 39349-39359.
78. Nakayama, K., Ishida, N., Shirane, M., Inomata, A., Inoue, T., Shishido, N., Horii, I., Loh, D.Y., and Nakayama, K. (1996). Mice lacking p27 Kip1 display increased body size, multiple organ hyperplasia, retinal dysplasia, and pituitary tumors. Cell 85, 707-720.
79. Nguyen, H., Gitig, D.M., and Koff, A. (1999). Cell-free degradation of p27 kip1, a G1 cyclin-dependent kinase inhibitor, is dependent on CDK2 activity and the proteasome. Mol. Cell. Biol. 19, 1190-1201. (Pubitemid 29046861)
80. Nishitani, H., Shiomi, Y., Iida, H., Michishita, M., Takami, T., and Tsurimoto, T. (2008). CDK inhibitor p21 is degraded by a proliferating cell nuclear antigen-coupled Cul4-DDB1Cdt2 pathway during S phase and after UV irradiation. J. Biol. Chem. 283, 29045-29052.
81. Noutsou, M., Duarte, A.M., Anvarian, Z., Didenko, T., Minde, D.P., Kuper, I., de Ridder, I., Oikonomou, C., Friedler, A., Boelens, R., et al. (2011). Critical scaffolding regions of the tumor suppressor Axin1 are natively unfolded. J. Mol. Biol. 405, 773-786.
82. Oldfield, C.J., Meng, J., Yang, J.Y., Yang, M.Q., Uversky, V.N., and Dunker, A.K. (2008). Flexible nets: disorder and induced fit in the associations of p53 and 14-3-3 with their partners. BMC Genomics 9 (Suppl), S1.
83. Ou, L., Ferreira, A.M., Otieno, S., Xiao, L., Bashford, D., and Kriwacki, R.W. (2011). Incomplete folding upon binding mediates Cdk4/cyclin D complex activation by tyrosine phosphorylation of inhibitor p27 protein. J. Biol. Chem. 286, 30142-30151.
84. Philipp-Staheli, J., Payne, S.R., and Kemp, C.J. (2001). p27 Kip1: regulation and function of a haploinsufficient tumor suppressor and its misregulation in cancer. Exp. Cell. Res. 264, 148-168. (Pubitemid 32989089)
85. Radivojac, P., Iakoucheva, L.M., Oldfield, C.J., Obradovic, Z., Uversky, V.N., and Dunker, A.K. (2007). Intrinsic disorder and functional proteomics. Biophys. J. 92, 1439-1456. (Pubitemid 46393458)
86. Rodriguez-Vilarrupla, A., Jaumot, M., Abella, N., Canela, N., Brun, S., Diaz, C., Estanyol, J.M., Bachs, O., and Agell, N. (2005). Binding of calmodulin to the carboxy-terminal region of p21 induces nuclear accumulation via inhibition of protein kinase C-mediated phosphorylation of Ser153. Mol. Cell. Biol. 25, 7364-7374. (Pubitemid 41105931)
87. Romero, P., Obradovic, Z., Li, X., Garner, E.C., Brown, C.J., and Dunker, A.K. (2001). Sequence complexity of disordered protein. Proteins 42, 38-48.
88. Rossig, L., Jadidi, A.S., Urbich, C., Badorff, C., Zeiher, A.M., and Dimmeler, S. (2001). Akt-dependent phosphorylation of p21 Cip1 regulates PCNA binding and proliferation of endothelial cells. Mol. Cell. Biol. 21, 5644-5657. (Pubitemid 32702467)
89. Russo, A.A., Jeffrey, P.D., Patten, A.K., Massague, J., and Pavletich, N.P. (1996). Crystal structure of the p27Kip1 cyclin-dependentkinase inhibitor bound to the cyclin A-Cdk2 complex. Nature 382, 325-331. (Pubitemid 26260452)
90. Schulman, B.A., Lindstrom, D.L., and Harlow, E. (1998). Substrate recruitment to cyclin-dependent kinase 2 by a multipurpose docking site on cyclin A. Proc. Natl. Acad. Sci. USA 95, 10453-10458. (Pubitemid 28413088)
91. Scott, M.T., Morrice, N., and Ball, K.L. (2000). Reversible phosphorylation at the C-terminal regulatory domain of p21 Waf1/Cip1 modulates proliferating cell nuclear antigen binding. J. Biol. Chem. 275, 11529-11537. (Pubitemid 30212810)
92. Serrano, M., Hannon, G.J., and Beach, D. (1993). A new regulatory motif in cell-cycle control causing specific inhibition of cyclin D/CDK4. Nature 366, 704-707. (Pubitemid 24036021)
93. Sheaff, R.J., Groudine, M., Gordon, M., Roberts, J.M., and Clurman, B.E. (1997). Cyclin E-CDK2 is a regulator of p27Kip1. Genes Dev. 11, 1464-1478.
94. Shin, I., Yakes, F.M., Rojo, F., Shin, N.-Y., Bakin, A.V., Baselga, J., and Arteaga, C.L. (2002). PKB/Akt mediates cell-cycle progresssion by phosphorylation of p27 KIP1 at threonine 157 and modulation of its cellular localization. Nat. Med. 8, 1145-1152. (Pubitemid 35175970)
95. Shoemaker, B.A., Portman, J.J., and Wolynes, P.G. (2000). Speeding molecular recognition by using the folding funnel: the fly-casting mechanism. Proc. Natl. Acad. Sci. USA 97, 8868-8873. (Pubitemid 30626639)
96. Sickmeier, M., Hamilton, J.A., LeGall, T., Vacic, V., Cortese, M.S., Tantos, A., Szabo, B., Tompa, P., Chen, J., Uversky, V.N., et al. (2007). DisProt: the database of disordered proteins. Nucleic Acids Res. 35, D786-D793. (Pubitemid 46056310)
97. Sivakolundu, S.G., Bashford, D., and Kriwacki, R.W. (2005). Disordered p27(Kip1) Exhibits Intrinsic structure resembling the Cdk2/cyclin A-bound conformation. J. Mol. Biol. 353, 1118-1128. (Pubitemid 41503276)
98. Suganuma, T. and Workman, J.L. (2011). Signals and combinatorial functions of histone modifications. Annu. Rev. Biochem. 80, 473-499.
99. Takaki, T., Echalier, A., Brown, N.R., Hunt, T., Endicott, J.A., and Noble, M.E. (2009). The structure of CDK4/cyclin D3 has implications for models of CDK activation. Proc. Natl. Acad. Sci. USA 106, 4171-4176.
100. Touitou, R., Richardson, J., Bose, S., Nakanishi, M., Rivett, J., and Allday, M.J. (2001). A degradation signal located in the C-terminus of p21 WAF1/CIP1 is a binding site for the C8 alpha-subunit of the 20S proteasome. EMBO J. 20, 2367-2375. (Pubitemid 32452854)
101. Toyoshima, H. and Hunter, T. (1994). p27, a novel inhibitor of G1 cyclin-Cdk protein kinase activity, is related to p21. Cell 78, 67-74. (Pubitemid 24228301)
102. Vavouri, T., Semple, J.I., Garcia-Verdugo, R., and Lehner, B. (2009). Intrinsic protein disorder and interaction promiscuity are widely associated with dosage sensitivity. Cell 138, 198-208.
103. Viglietto, G., Motti, M.L., Bruni, P., Melillo, R.M., D'Alessio, A., Califano, D., Vinci, F., Chiappetta, G., Tsichlis, P., Bellacosa, A., et al. (2002). Cytoplasmic relocalization and inhibition of the cyclin-dependent kinase inhibitor p27 Kip1 by PKB/Akt-mediated phosphorylation in breast cancer. Nat. Med. 8, 1136-1144. (Pubitemid 35175969)
104. Vlach, J., Hennecke, S., and Amati, B. (1997). Phosphorylationdependent degradation of the cyclin-dependent kinase inhibitor p27. EMBO J. 16, 5334-5344. (Pubitemid 27380141)
105. Waga, S., Hannon, G.J., Beach, D., and Stillman, B. (1994). The p21 inhibitor of cyclin-dependent kinases controls DNA replication by interaction with PCNA. Nature 369, 574-578. (Pubitemid 24192528)
106. Wander, S.A., Zhao, D., and Slingerland, J.M. (2011). p27: a barometer of signaling deregulation and potential predictor of response to targeted therapies. Clin. Cancer Res. 17, 12-18.
107. Wang, W., Nacusi, L., Sheaff, R.J., and Liu, X. (2005a). Ubiquitination of p21 Cip1/WAF1 by SCFSkp2: substrate requirement and ubiquitination site selection. Biochemistry 44, 14553-14564. (Pubitemid 41567463)
108. Wang, Y., Filippov, I., Richter, C., Luo, R., and Kriwacki, R.W. (2005b). Solution NMR studies of an intrinsically unstructured protein within a dilute, 75 kDa eukaryotic protein assembly; probing the practical limits for efficiently assigning polypeptide backbone resonances. ChemBioChem 6, 2242-2246.
109. Wang, Y., Fisher, J.C., Mathew, R., Ou, L., Otieno, S., Sublet, J., Xiao, L., Chen, J., Roussel, M.F., and Kriwacki, R.W. (2011). Intrinsic disorder mediates the diverse regulatory functions of the Cdk inhibitor p21. Nat. Chem. Biol. 7, 214-221.
110. Ward, J.J., Sodhi, J.S., McGuffin, L.J., Buxton, B.F., and Jones, D.T. (2004). Prediction and functional analysis of native disorder in proteins from the three kingdoms of life. J. Mol. Biol. 337, 635-645. (Pubitemid 38326883)
111. Watanabe, H., Pan, Z.Q., Schreiber-Agus, N., DePinho, R.A., Hurwitz, J., and Xiong, Y. (1998). Suppression of cell transformation by the cyclin-dependent kinase inhibitor p57KIP2 requires binding to proliferating cell nuclear antigen. Proc. Natl. Acad. Sci. USA 95, 1392-1397.
112. Weiss, R.H. (2003). p21Waf1/Cip1 as a therapeutic target in breast and other cancers. Cancer Cell 4, 425-429. (Pubitemid 38050039)
113. Xiong, Y., Hannon, G.J., Zhang, H., Casso, D., Kobayashi, R., and Beach, D. (1993). p21 is a universal inhibitor of cyclin kinases. Nature 366, 701-704. (Pubitemid 24036020)
114. Yan, Y., Zhang, X., and Legerski, R.J. (2011). Artemis interacts with the Cul4A-DDB1DDB2 ubiquitin E3 ligase and regulates degradation of the CDK inhibitor p27. Cell Cycle 10, 4098-4109.
115. Yoon, M.K., Venkatachalam, V., Huang, A., Choi, B.S., Stultz, C.M., and Chou, J.J. (2009). Residual structure within the disordered C-terminal segment of p21 Waf1/Cip1/Sdi1 and its implications for molecular recognition. Protein Sci. 18, 337-347.
116. Yu, Z.K., Gervais, J.L., and Zhang, H. (1998). Human CUL-1 associates with the SKP1/SKP2 complex and regulates p21 CIP1/WAF1 and cyclin D proteins. Proc. Natl. Acad. Sci. USA 95, 11324-11329.
117. Zhang, H., Hannon, G.J., and Beach, D. (1994). p21-copntaining cyclin kinases exist in both active and inactive states. Genes Dev. 8, 1750-1758.
118. Zhou, B.P., Liao, Y., Xia, W., Spohn, B., Lee, M.-H., and Hung, M.-C. (2001). Cytoplasmic localization of p21 Cip1/WAF1 by Akt-induced phosphorylation in Her - 2/neu-overexpressing cells. Nat. Cell Biol. 3, 245-252. (Pubitemid 32201319)
119. Zhu, H., Nie, L., and Maki, C.G. (2005). Cdk2-dependent Inhibition of p21 stability via a C-terminal cyclin-binding motif. J. Biol. Chem. 280, 29282-29288. (Pubitemid 41161383)